Form 4: Veracyte Director Karin Eastham Acquires Shares

Director Karin Eastham of Veracyte, Inc. acquired 5,272 shares of common stock on June 11, 2026, increasing her beneficial ownership.

Summary

• Karin Eastham, a Director at Veracyte, Inc., acquired 5,272 shares of common stock on June 11, 2026.
• This transaction resulted in a total of 18,826 shares of common stock beneficially owned by Ms. Eastham following the reported transaction.
• The acquisition was made at a price of $0, indicating it was likely an award or grant.
• The shares acquired are restricted stock units that vest in full on the first anniversary of the grant date or prior to the company's next annual meeting, whichever is earlier.
• Vesting also occurs immediately prior to a change in control of the Issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents an insider acquisition of stock, which can be a positive signal, but it is a standard grant of restricted stock units with vesting conditions.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition increases the reporting person's beneficial ownership in the company.

Risks

• The restricted stock units are subject to vesting conditions, meaning immediate full ownership is contingent on time or a change in control.
• The value of the acquired shares is subject to market fluctuations.

Future Outlook

The restricted stock units will vest in full on the first anniversary of the grant date or immediately prior to the Company's next annual meeting of stockholders, if earlier. Vesting will also occur in full in the event of a change in control of the Issuer.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are common in the biotechnology and diagnostics sector as a way to align executive interests with shareholders and signal long-term commitment.

Stakeholder Impact

• Shareholders: Increased beneficial ownership by a director may be viewed positively, aligning director interests with shareholders.
• Employees: The vesting schedule for restricted stock units is a standard component of executive compensation.

Next Steps

• Vesting of restricted stock units on the first anniversary of the grant date or prior to the next annual meeting.
• Potential vesting in the event of a change in control.

Key Dates

Keywords

Veracyte, VCYT, Form 4, Insider Trading, Stock Acquisition, Director, Restricted Stock Units, Beneficial Ownership